FindTrial
Sign In

The clinical application of the TEAS in ERAS

Application of transcutaneous electrical acupoint stimulation in enhanced recovery after surgery of patients undergoing laparoscopic colorectal cancer resection: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012527
Enrollment
Unknown
Registered
2017-09-01
Start date
2017-08-15
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgery of patients undergoing laparoscopic colorectal cancer

Interventions

The control group:blank group
The ERAS preanalgesia group:TAP preanalgesia
The ERAS preanalgesic and TEAS group:TEAS

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) signing informed consent form; 2) select the patients who have the laparoscopic radical rectal cancer; 3) ASA I-II; 4) patients aged 18 to 75 years old.

Exclusion criteria

Exclusion criteria: The exclusion criteria included lung, liver, kidney and other significant systemic organ dysfunction, severe cardiovascular disease, and ropivacaine allergy.

Design outcomes

Primary

MeasureTime frame
VAS;Postoperative rapid recovery index observation;—

Secondary

MeasureTime frame
The amount of Rifentanyl in the technique;—

Countries

China

Contacts

Public ContactJianbing Xiao

Guangzhou University of Chinese Medicine

442695103@qq.com+86 13802728753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026